Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Solid organ transplantation after hematopoietic stem cell transplantation in childhood: A multicentric retrospective survey

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Cyclosporine and COVID-19: Risk or favorable?

    Research output: Contribution to journalReviewResearchpeer-review

  2. Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk of genital warts in renal transplant recipients-A registry-based, prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Blood chimerism in dizygotic monochorionic twins during five years observation

    Research output: Contribution to journalJournal articleResearch

  • EBMT Pediatric Disease Working Party
View graph of relations

We report data obtained from a retrospective multicenter pediatric survey on behalf of the European Society for Blood and Marrow Transplantation (EBMT). Information on solid organ transplantation (SOT) performed in pediatric recipients of either autologous or allogeneic hematopoietic stem cell transplantation (HSCT) between 1984 and 2016 was collected in 20 pediatric EBMT Centers (25.6%). Overall, we evaluated data on 44 SOTs following HSCT including 20 liver (LTx), 12 lung (LuTx), 6 heart (HTx), and 6 kidney (KTx) transplantations. The indication for SOT was organ failure related to intractable graft-vs-host disease in 16 children (36.3%), acute or chronic HSCT-related toxicity in 18 (40.9%), and organ dysfunction related to the underlying disease in 10 (22.8%). The median follow-up was 10.9 years (95% confidence interval: 1.7-29.5). The overall survival rate at 1 and 5 years after SOT was 85.7% and 80.4%, respectively: it was 74% and 63.2% after LTx, 83.2% after HTx, and 100% equally after LuTx and KTx. This multicenter survey confirms that SOT represents a promising option in children with severe organ failure occurring after HSCT. Additional studies are needed to further establish the effectiveness of SOT after HSCT and to better understand the mechanism underlying this encouraging success.

Original languageEnglish
JournalAmerican Journal of Transplantation
Issue number6
Pages (from-to)1798-1805
Number of pages8
Publication statusPublished - 2019

ID: 58992911